Abstract: Some embodiments provide a compound represented by Formula 1: wherein R1, R2, R3, R4, R5, R6, R7 and R8 are independently H, C1-C3 alkyl, or C1-3 perfluoroalkyl; HT is optionally substituted carbazoyl, optionally substituted phenylcarbazolyl, optionally substituted (phenylcarbazolyl)phenyl, optionally substituted phenylnaphthylamine, or optionally substituted diphenylamine; and ET optionally substituted benzimidazol-2-yl, optionally substituted benzothiazol-2-yl, optionally substituted benzoxazol-2-yl, optionally substituted 3,3?-bipyridin-5-yl, optionally substituted quinolin-8-yl, optionally substituted quinolin-5-yl, or optionally substituted quinoxalin-5-yl. Other embodiments provide an organic light-emitting diode device comprising a compound of Formula 1.

Abstract: This disclosure relates to compounds for use in light-emitting devices are described herein. These compounds may include a biphenyl that includes four substituents, such as benzoxazolyl, benzothiazolyl, or benzimidazolyl substituents, such as a compound represented by Formula 1. These compounds can incorporated into a nanostructure material or a plurality of nanostructures, which can be useful for light-scattering or light-extraction, for example, to increase the efficiency of light-emitting devices.

Abstract: Optionally substituted ambipolar naphthalene compounds useful in light-emitting devices are described, including without limitation 9-(3-(10-(3-(1-phenyl-1H-benzo[d]imidazol-2-yl)phenyl)anthracen-9-yl)phenyl)-9H-carbazole and 9-(3-(10-(3-(1-phenyl-1H-benzo[d]imidazol-2-yl)phenyl)anthracen-9-yl)phenyl)-9H-carbazole.

Abstract: Polyphenylene compounds such as compounds represented by Formulas 1-28 may be used in electronic devices such as organic light-emitting devices. For example, the compounds may be used as host material in an emissive layer.

Abstract: Disclosed herein are compounds represented by a formula: Wherein Ar1, Cb, Ph1, Het1, and A are described herein. Compositions and light-emitting devices related thereto are also disclosed.

Abstract: Described herein are devices, compositions, and methods for improving color discernment.

Abstract: Some embodiments provide a compound represented by Formula 2B: wherein Ph1 and Ph2 are independently optionally substituted 1,4-interphenylene or optionally substituted 1,3-interphenylene, y may be 0 or 1, and z may be 0 or 1. In some embodiments, R9 and R10 are independently H, C1-3 alkyl, or C1-3 perfluoroalkyl. In some embodiments, R11, R12, R13, R14, R15, R16, R17, R18, R19, R20, R21, and R22 are independently selected from the group consisting of H, C1-12 alkyl, C1-6F1-13 fluoroalkyl, and optionally substituted phenyl. Other embodiments provide an organic light-emitting diode device comprising a compound of Formula 2B.

Abstract: Compounds useful in porous films for light extraction and/or light scattering in electronic devices, such as light-emitting devices, are described herein. These compounds may be represented by Formula 1, as described herein.

Abstract: Some porous films, such as organic non-polymeric porous films, may be useful for light outcoupling to increase light-emitting device efficiency. They may also be used for light scattering in other devices and for other applications related to the transfer of light.

Abstract: Optionally substituted bispyridinylbenzene compounds useful in light-emitting devices include, but are not limited to, 1,3-bis(5-(9H-carbazol-9-yl)pyridin-3-yl)benzene and 9,9?-(5,5?-(5-methyl-1,3-phenylene)bis(pyridine-5,3-diyl))bis(9H-carbazole).

Abstract: Optionally substituted bipyridine compounds, optionally substituted phenylbipyridine compounds, or optionally substituted bis-phenylbipyridine compounds may be useful in light-emitting devices.

Abstract: Some embodiments provide a compound represented by Formula 2B: wherein Ph1 and Ph2 are independently optionally substituted 1,4-interphenylene or optionally substituted 1,3-interphenylene, y may be 0 or 1, and z may be 0 or 1. In some embodiments, R9 and R10 are independently H, C1-3 alkyl, or C1-3 perfluoroalkyl. In some embodiments, R11, R12, R13, R14, R15, R16, R17, R18, R19, R20, R21, and R22 are independently selected from the group consisting of H, C1-12 alkyl, C1-6F1-13 fluoroalkyl, and optionally substituted phenyl. Other embodiments provide an organic light-emitting diode device comprising a compound of Formula 2B.

Abstract: Some embodiments provide a compound represented by Formula 1. Other embodiments provide an organic light-emitting diode device, such as a light-emitting device for phototherapy, comprising a compound of Formula 1. Other embodiments provide an organic light-emitting device optionally comprising a wavelength convertor. Methods related to the treatment of diseases using phototherapy area also described.

Abstract: Some embodiments provide a compound represented by Formula 1: wherein R1, R2, R3, R6, R7, and R8 are independently selected from the group consisting of H, optionally substituted C1-12 alkyl, optionally substituted phenyl, optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl; provided that: at least one of R1, R2, and R3 is selected from optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl and at least one of R6, R7, and R8 is selected from optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl; and R4 and R5 are independently selected from the group consisting of H, optionally substituted C1-12 alkyl, optionally substituted phenyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl.

Abstract: Some embodiments provide a compound represented by Formula 1: wherein R1, R2, R3, R6, R7, and R8 are independently selected from the group consisting of H, optionally substituted C1-12 alkyl, optionally substituted phenyl, optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl; provided that: at least one of R1, R2, and R3 is selected from optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl and at least one of R6, R7, and R8 is selected from optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl; and R4 and R5 are independently selected from the group consisting of H, optionally substituted C1-12 alkyl, optionally substituted phenyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl.

Abstract: Some embodiments provide a compound represented by Formula 1: wherein R1, R2, R3, R6, R7, and R8 are independently selected from the group consisting of H, optionally substituted C1-12 alkyl, optionally substituted phenyl, optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl; provided that: at least one of R1, R2, and R3 is selected from optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl and at least one of R6, R7, and R8 is selected from optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl; and R4 and R5 are independently selected from the group consisting of H, optionally substituted C1-12 alkyl, optionally substituted phenyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl.

Abstract: Some embodiments provide a compound represented by Formula 1: wherein R1, R2, R3, R6, R7, and R8 are independently selected from the group consisting of H, optionally substituted C1-12 alkyl, optionally substituted phenyl, optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl; provided that: at least one of R1, R2, and R3 is selected from optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl and at least one of R6, R7, and R8 is selected from optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl; and R4 and R5 are independently selected from the group consisting of H, optionally substituted C1-12 alkyl, optionally substituted phenyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl.

Abstract: Some embodiments provide a compound represented by Formula 1: wherein R1, R2, R3, R6, R7, and R8 are independently selected from the group consisting of H, optionally substituted C1-12 alkyl, optionally substituted phenyl, optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl; provided that: at least one of R1, R2, and R3 is selected from optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl and at least one of R6, R7, and R8 is selected from optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl; and R4 and R5 are independently selected from the group consisting of H, optionally substituted C1-12 alkyl, optionally substituted phenyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl.

Abstract: Some embodiments provide a compound represented by Formula 1: wherein R1, R2, R3, R6, R7, and R8 are independently selected from the group consisting of H, optionally substituted C1-12 alkyl, optionally substituted phenyl, optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl; provided that: at least one of R1, R2, and R3 is selected from optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl and at least one of R6, R7, and R8 is selected from optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl; and R4 and R5 are independently selected from the group consisting of H, optionally substituted C1-12 alkyl, optionally substituted phenyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl.

Abstract: Disclosed herein are compounds represented by a formula: Wherein Ar1, Cb, Ph1, Het1, and A are described herein. Compositions and light-emitting devices related thereto are also disclosed.